Sarah Tabrizi's presentation about the Ionis clinical trial, November 6, 2017

AWC-4947.jpg

Sarah Tabrizi presented the latest from the “first in human” drug trial which “silences” – or turns down – the HD gene at the Hereditary Disease Foundation's 50th Anniversary Symposium and Gala on November 6, 2017.

Watch her presentation here.

Sarah also received the 2018 Leslie Gehry Brenner Prize for Innovation in Science that evening.